Content of Phenols, Flavonoids and Antihyperuricemic Activity of Leaves And Rhizomes of Smilax Purhampuy Ruiz
DOI:
https://doi.org/10.56294/saludcyt20241037Keywords:
Smilax Purhampuy, Phenols, Flavonoids, Uric Acid, Xanthine OxidaseAbstract
Introduction: Smilax purhampuy is traditionally used for the treatment of chronic gastritis,
cystitis, arthritis and inflammation of the prostate; however, it lacks scientific studies that support its traditional use.
Objective: To estimate the chemical composition and antihyperuricemic activity of hydroalcoholic extracts from leaves and rhizomes of S. purhampuy.
Method: the dry material of leaves and rhizomes of the species was used for the elaboration of the extracts by maceration with 80 % hydroalcoholic solvent. Total phenols were quantified by Folin-Ciocalteu and total flavonoids by the aluminum chloride colorimetric method. Antihyperuricemic activity was evaluated in rats using the potassium oxonate induction model; the extracts were tested at doses of 125, 250 and 400 mg/kg and allopurinol 10 mg/kg was used as a positive control. The uric acid content in blood serum was quantified and the enzymatic activity of xanthine oxidase was determined.
Results: in the phytochemical determinations, significant differences were observed in the content of each evaluated metabolite, fundamentally associated with the characteristics of each plant organ. The highest content of phenols (4.08 mg EAG/g) and flavonoids (1.01 mg EQ/g) was found in the leaf extract. The extracts of leaves and rhizomes showed a significant decrease in the levels of uric acid in blood serum (156.31 µmol/L y 167.58 µmol/L, respectively) and in the activity of the enzyme xanthine oxidase at all doses tested, being more marked in the extract of leaves at 400 mg/kg.
Conclusions: the results provide the first findings of the antihyperuricemic potential of the species and make an important contribution to the knowledge of its chemical composition
References
1. Bernardes AC, Brandão CG, Araújo MC, Guimarães DA. In vivo anti-hyperuricemic activity of sesquiterpene lactones from Lychnophora species. Revista Brasileira de Farmacognosia 2019 [acceso: 10/01/2020]; 29:241-245. Disponible en: https://doi.org/10.1016/j.bjp.2018.12.008
2. Yusuf A, Dang XT, Ngoc QT, Ngoc MT, Mai VT and Duc VT. antihyperuricemia, antioxidant, and antibacterial activities of Tridax procumbens L. Foods 2019; 8(21). DOI: 10.3390/foods8010021.
3. Battelli MG, Bortolotti M, Polito L, Bolognesi A. The role of xanthine oxidoreductase and uric acid in metabolic syndrome. Biochim. Biophys. Acta (BBA) Mol. Basis Dis. 2018; 1864:2557-2565. DOI: 10.1016/j.bbadis.2018.05.000
4. Vegas CJA, Peraza RD, Vegas PC, Vegas PL. Ácido úrico como factor pronóstico de discapacidad neurológica y/o mortalidad en la enfermedad cerebrovascular isquémica aterotrombótica. Rev. Chil. Neurocirugía 2019; 45:45-55. Disponible en: https://doi.org/10.36593/rev.chil.neurocir.v45i1.10
5. Benn CL, Dua P, Gurrell R, Loudon P, Pike A, Storer RI, et al. Physiology of hyperuricemia and urate-lowering treatments. Front. Med. 2018 [acceso: 20/02/2020]; 5(160). Disponible en: https://doi.or/10.3389/fmed.2018.00160
6. Chen L, Luo Z, Wang M, Cheng J, Li F, Lu H, et al. The efficacy and mechanism of chinese herbal medicines in lowering serum uric acid levels: a systematic review. Front. Pharmacol. 2021; 11. DOI: 10.3389/fphar.2020.578318
7. Ahmad HI, Shoaib KHM, Akhtar N. Phenolic, flavonoid content and radical scavenging activity of Smilax China with its inhibitory potential against clinically important enzymes. Natural Product Research 2019:3-6. DOI:10.1080/14786419.2019.1648463
8. Da Cunha APS, Ferreira LS, Pasuch AJ, Petrica EEA, Sinhorin AP, Sinhorin VDG. Investigation of the possible protective effect of Smilax fluminensis Steud. leaf in mice subjected to oxidative stress by paracetamol. Bioscience Journal 2021; 37, e37070. Disponible en: https://doi.org/10.14393/Bj-v37n0a2021-53862
9. Global Biodiversity Information Facility (GBIF). Smilax purhampuy Ruiz. Copenhagen: GBIF; 2012 [acceso 05/08/2019]. Disponible en: https://www.gbif.org/species/5295631
10. JR Global del Perú S.A.C. Ficha Técnica-Zarzaparrilla. Lima: Inkaplus.com; 2011 [acceso 08/07/2019]. Disponible en: http://www.yumpu.com/es/document/view/15083310zarzaparrilla-inkaplus
11. Soledispa CPA, Mangas MR, Gutiérrez GYI, Sarmiento TGM. Perfil fitoquímico y actividad antiinflamatoria de hojas y rizomas de Smilax purhampuy Ruiz. Revista Cubana de Farmacia 2022; 55(1):e742.
12. Soledispa P, Santos OE, Miranda M, Pacheco R, Gutiérrez GYI and Scull R. Molecular barcode and morphological analysis of Smilax purhampuy Ruiz, Ecuador. PeerJ 2021 [acceso: 20/01/2022]; 9:e11028. Disponible en: http://doi.org/10.7717/peerj.11028
13. Minsap. NRSP 312. Norma Ramal. Medicamentos de origen vegetal. Extractos fluidos y tinturas. Métodos de ensayo. La Habana, Minsap; 1992 p. 15-19.
14. Miranda MM, Cuéllar AC. Manual de prácticas de laboratorio. Farmacognosia y productos naturales. Ciudad de La Habana: Editorial Félix Varela; 2000. p. 56-60.
15. Chlopicka J, Pasko P, Gorinstein S, Jedryas A, Zagrodzki P. Total phenolic and total flavonoid content, antioxidant activity and sensory evaluation of pseudocereal breads. LWT- Food Sci Technol. 2012; 46:548-555. DOI: 10.1016/j.lwt.2011.11.009
16. Chang CC, Yang MN, Wen HM, Chern JC. Estimation of total flavonoid content in propolis by two complementary colorimetric methods. J Food Drug Anal. 2002; 10(3):178-182. DOI: 10.38212/2224-6614.2748
17. Pourmorad F, Hosseinimerhr SJ, Shahabimajd N. Antioxidant activity, phenol and flavonoid contents of some selected Iranian medicinal plants. Afr J Biotechnol. 2006 [acceso: 20/02/2020]; 5(11):1142-1145. Disponible en: https://www.researchgate.net/publication/27797479
18. Mohammad MK, Almasri IM, Tawaha K, Issa A, Al-Nadaf A, Hudaib M, et al. Antioxidant, antihyperuricemic and xanthine oxidase inhibitory activities of Hyoscyamus reticulatus. Pharmaceutical Biology 2010; 48(12):1376-63. DOI: 10.3109/13880209.2010.483521
19. Nguyen TD, Thuong PT, Hwang IH, Hoang TKH, Nguyen MK, Nguyen HA. Anti-Hyperuricemic, anti-inflammatory and analgesic effects of Siegesbeckia orientalis L. resulting from the fraction with high phenolic content. BMC Complementary and Alternative Medicine 2017; 17(191). DOI: 10.1186/s12906-017-1698-z.
20. Diehl KH, Hull R, Morton D, Pfister R, Rabemampianina Y, Smith D, et al. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J. Appl. Toxicol. 2001;21(1):15-23. DOI:10.1002/jat.727
21. WMA. Declaración de la AMM sobre el uso de animales en la investigación biomédica. WMA: Buenos Aires, Argentina; 2016 [acceso 02/03/2017]. Disponible en: https://www.wma.net/es/policiespost/declaracionde-la-amm-sobre-el-uso-deanimales- en-lainvestigacionbiomedica/
22. Böehringer M. Biochemica Information. Indianapolis, Estados Unidos; 1987, p-85.
23. Al-Snafi AE. Phenolics and flavonoids contents of medicinal plants, as natural ingredients for many therapeutic purposes- A review. IOSR Journal Of Pharmacy 2021 [acceso: 20/02/2022]; 10(7):42-81. Disponible en: https://www.researchgate.net/publication/343111170
24. Mutha RE, Tatiya AU and Surana SJ. Flavonoids as natural phenolic compounds and their role in therapeutics: an overview. Future Journal of Pharmaceutical Sciences 2021. Disponible en: https://doi.org/10.1186/s43094-020-00161-8
25. Shorinwa OA and Shatange DD. Antioxidant and Hepatoprotective Activity of Leaf Extract of Smilax anceps Wild. Diabetes Complications 2022; 6(1):1-8. DOI: 10.33425/2639-9326.1098
26. Fonseca JC, Barbosa MA, Silva ICA, Duarte-Almeida JM, Castro AHF, dos Santos LLAR. Antioxidant and allelopathic activities of Smilax brasiliensis Sprengel (Smilacaceae). South African Journal of Botany 2017 [acceso: 15/05/2019]; 111:336-340. Disponible en: http://dx.doi.org/10.1016/j.sajb.2017.04.003
27. Malge NR, Bandara AMPW, Keerthirathna WLR, Dissanayake DMI, Kamal PP, Witharana C, et al. Antioxidant and anti-proliferative activities of Smilax Zeylanica root and rhizome extract against liver carcinoma cells. Journal of Herbs, Spices & Medicinal Plants 2021 [acceso: 20/02/2022]; 27(2):188-199. Disponible en: https://doi.org/10.1080/10496475.2021.1891178
28. Yuan Y, Tang X, Jia Z, Li C, Ma J and Zhang J. The effects of ecological factors on the main medicinal components of Dendrobium offcinale under different cultivation modes. Forests 2020; 11(94): 16 pages. DOI:10.3390/f11010094.
29. Zargoosh Z, Ghavam M, Bacchetta G & Tavili A. Effects of ecological factors on the antioxidant potential and total phenol content of Scrophularia striata Boiss Scientific Reports 2019 [acceso: 20/02/2020]; 9:16021. Disponible en: https://doi.org/10.1038/s41598-019-52605-8
30. Scanu A, Luisetto R, Ramonda R, Spinella P, Sfriso P, Galozzi P, et al. Anti-inflammatory and hypouricemic effect of bioactive compounds: molecular evidence and potential application in the management of gout. Curr. Issues Mol. Biol. 2022; 44:5173-5190. Disponible en: https://doi.org/10.3390/cimb44110352
31. Naz H, Naz S, Miraj R, Zaheer A, Azam N, Mughal IS, et al. The Effect of Berberine, a Drug From Chinese Folk Medicine, on Serum and Urinary Uric Acid Levels in Rats With Hyperuricemia. Cureus 2021; 13(2): e13186. DOI: 10.7759/cureus.13186
32. Oh DR, Kim JR, Choi CY, Choi C, Na C, Kang BY, et al. Effects of ChondroT on potassium oxonate induced hyperuricemic mice: downregulation of xanthine oxidase and urate transporter 1. BMC Complementary and Alternative Medicine 2019 [acceso: 20/02/2020]; 19:10. Disponible en: https://doi.org/10.1186/s12906-018-2415-2
33. Park JE, Yeom Z, Park KT, Han EH, Yu HJ, Kang HS, et al. Hypouricemic effect of ethanol extract of Aster glehni leaves in potassium oxonate-induced hyperuricemic rats. Clin Nutr Res. 2018 [acceso: 20/02/2020]; 7(2):126-135. Disponible en: https://doi.org/10.7762/cnr.2018.7.2.126.
34. Oliveira FAS, Ferreira RC, Parentoni RN, Andrade CCN, Lopes ALO, Cruz ALG, et al. Valores de referência de parâmetros bioquímicos e hematológicos de Rattus novergicus (Wistar) da Unidade de Produção Animal do Instituto de Pesquisa em Fármacos e Medicamentos da Universidade Federal da Paraíba. Scientia Plena 2021; 17(3):1-13. DOI: 10.14808/sci.plena.2021.034901
35. Cicero AFG, Fogacci F, Cincione RI, Tocci G, Borghi C. Clinical effects of xanthine oxidase inhibitors in hyperuricemic patients. Med Princ Pract 2021;30:122-130. DOI: 10.1159/000512178
36. Torres RML, García CE, Soto PGA, Aradillas GC, Cubillas TAC. Evaluación de la toxicidad aguda in vivo del extracto etanólico y acuoso de Calea urticifolia. Botanical Sciences 2016; 94 (1):133-140.
37. Aular Y, Villamizar M, Pérez Y, Pérez V. Composición química y toxicidad aguda oral del aceite esencial de Lippia alba en ratones. Rev. Salus. UC. 2016; 20(1):43-51.
38. Li X, Jin W, Zhang W, Zheng G. The inhibitory kinetics and mechanism of quercetin-3-o-rhamnoside and chlorogenic acid derived from Smilax china L. EtOAc Fraction on xanthine oxidase. Int. J. Biol. Macromol. 2022 [acceso: 30/01/2023]; 213:447-455. Disponible en: https://doi.org/10.1016/j.ijbiomac.2022.5.188
39. Xu L, Li LL, and Dong GJ. Traditional Chinese herbal medicine plays a role in the liver, kidney, and intestine to ameliorate hyperuricemia according to experimental studies. Hindawi. Evidence-Based Complementary and Alternative Medicine 2021 [acceso: 2/02/2023]; 2021, 13 pages. Disponible en: https://doi.org/10.1155/2021/4618352
40. Liu L, Zhang L, Ren L, Xie Y. Advances in structures required of polyphenols for xanthine oxidase inhibition. Food Frontiers 2020; 1:152-167. DOI: 10.1002/fft2.27
Published
Issue
Section
License
Copyright (c) 2024 Pilar A. Soledispa Cañarte, Raisa Mangas Marín , Glenda M. Sarmiento Tomalá , Byron E. Zavala ec Soledispa (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
